Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine

Constant efforts to prevent infections by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are actively carried out around the world. Several vaccines are currently approved for emergency use in the population, while ongoing studies continue to provide information on their safety and eff...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Luisa F. Duarte, Nicolás M. S. Gálvez, Carolina Iturriaga, Felipe Melo-González, Jorge A. Soto, Bárbara M. Schultz, Marcela Urzúa, Liliana A. González, Yaneisi Vázquez, Mariana Ríos, Roslye V. Berríos-Rojas, Daniela Rivera-Pérez, Daniela Moreno-Tapia, Gaspar A. Pacheco, Omar P. Vallejos, Guillermo Hoppe-Elsholz, María S. Navarrete, Álvaro Rojas, Rodrigo A. Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Gang Zeng, Weining Meng, José V. González-Aramundiz, Pablo A. González, Katia Abarca, Susan M. Bueno, Alexis M. Kalergis
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2021-09-01
Cyfres:	Frontiers in Immunology
Pynciau:	CoronaVac phase 3 clinical trial SARS-CoV-2 COVID-19 vaccines breakthrough cases
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.742914/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!